Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

1 week J&J Trading Near 52-Week Low: Should You Sell the Stock? Zacks

Those who own the stock may stay invested for some time as J&J looks optimistic about a better performance in 2025.

Johnson & Johnson (JNJ)

  X     

5 hours J&J and United Health among Thursday’s market cap stock movers Investing.com

   X     

7 hours J&J Pauses Sales of Atrial Fibrillation Device, Stock Down Zacks

   X     

1 day AMD, J&J lead market cap stock movers on Wednesday Investing.com

   X     

1 day J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product Investor's Business Daily

   X     

1 day Johnson & Johnson stock sinks on Varipulse concerns Investing.com

   X     

1 day Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer Seeking Alpha

   X     

1 day Johnson & Johnson stock reaches 52-week low as markets fall FXStreet

   X     

2 days Johnson & Johnson: A Potential Beneficiary Of A Great Rotation Seeking Alpha

   X     

2 days Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors Zacks

   X     

2 days Top Research Reports for NVIDIA, Meta Platforms & Johnson & Johnson Zacks

   X     

2 days Johnson & Johnson: I’m Saying Yes To This Mess Seeking Alpha

   X     

7 days The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

1 week Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

1 week Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note Zacks

   X     

2 weeks Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal Yahoo Finance

   X     

2 weeks J&J Snack Foods: Shares Are Still Too Expensive Seeking Alpha

   X     

2 weeks Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

2 weeks Johnson & Johnson (JNJ) Ascends But Remains Behind Market: Some Facts to Note Zacks

   X     

3 weeks Johnson & Johnson: Dividend Legend At A Discount Seeking Alpha

   X     

3 weeks FDA Gives CRL to J&J’s BLA for Subcutaneous Rybrevant in NSCLC Zacks

   X     

3 weeks Johnson & Johnson (JNJ) Stock Declines While Market Improves: Some Information for Investors Zacks

   X     

4 weeks J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports Investing.com

   X     

4 weeks Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

4 weeks Johnson & Johnson (JNJ) Stock Moves -0.25%: What You Should Know Zacks

   X     

1 month Johnson & Johnson Just Paid Investors: Here’s How Much They Received 24/7 Wall St.

   X     

1 month Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Seeking Alpha

   X     

1 month Pharma Stock Roundup: LLY’s Zepbound Success, FDA Updates for MRK, JNJ Zacks

   X     

1 month The Zacks Analyst Blog Highlights Home Depot, Johnson & Johnson, Salesforce, Preformed Line and Cooper-Standard Zacks

   X     

1 month Top Analyst Reports for Home Depot, Johnson & Johnson & Salesforce Zacks

   X     

1 month Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

   X     

1 month J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids Zacks

   X     

1 month J&J baby powder lawsuits stay paused amid bankruptcy trial plans Investing.com

   X     

1 month Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know Zacks

   X     

1 month How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding Seeking Alpha

   X     

2 months J&J Seeks FDA Nod for Subcutaneous Tremfya as Induction Regimen in UC Zacks

   X     

2 months J&J Loses Around $24B in a Month: How to Play the Stock? Zacks

   X     

2 months Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive Seeking Alpha

   X     

2 months Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

2 months Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months CHMP Endorses J&J’s Rybrevant-Lazcluze Combo for Use in NSCLC Zacks

   X     

2 months Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program Yahoo Finance

   X     

2 months Why Is Johnson & Johnson (JNJ) Down 6.7% Since Last Earnings Report? Zacks

   X     

2 months Compared to Estimates, J&J Snack Foods (JJSF) Q4 Earnings: A Look at Key Metrics Zacks

   X     

2 months Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.2% – Time to Sell? MarketBeat

   X     

2 months Johnson & Johnson (NYSE:JNJ) Sees Significant Drop in Short Interest MarketBeat

   X     

2 months The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction Zacks

   X     

2 months Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific Zacks

   X     

2 months Johnson & Johnson (NYSE:JNJ) Stock Price Up 0.2% – Still a Buy? MarketBeat

   X     

2 months J&J Snack Foods (NASDAQ:JJSF) Earns Buy Rating from Benchmark MarketBeat

   X     

2 months Johnson & Johnson (NYSE:JNJ) Shares Sold by State of Alaska Department of Revenue MarketBeat

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News